High‐dose Vitamin D harmful for bone health in women, reveals study
Researchers do not support the benefit of high‐dose vitamin D supplementation for bone health of postmenopausal women.Canada: High-dose vitamin D supplementation results in greater losses in total bone mineral density (BMD) in women than in men, suggests a recent study. The findings from the study were presented at the virtual American Society for Bone and Mineral Research (ASBMR) meeting...
Researchers do not support the benefit of high‐dose vitamin D supplementation for bone health of postmenopausal women.
Canada: High-dose vitamin D supplementation results in greater losses in total bone mineral density (BMD) in women than in men, suggests a recent study. The findings from the study were presented at the virtual American Society for Bone and Mineral Research (ASBMR) meeting and published in the Journal of Bone and Mineral Research.
The results are significant as vitamin D supplementation is administered widely to postmenopausal women for the prevention of osteoporosis. The study raises the possibility of harm from high dose vitamin D supplementation in females.
The study by Lauren A Burt, University of Calgary, Calgary, Canada, and colleagues whether three years of high‐dose vitamin D supplementation (400, 4000, 10,000 IU) in healthy vitamin D‐sufficient individuals aged 55‐70 years (serum 25(OH)D 30‐125 nmol/L at baseline), results in a negative dose‐response relationship for bone density and strength and whether the response differs between males and females.
The study included 311 participants (53% male). They were randomized to receive 400 (M=61, F=48), 4000 (M=51, F=49), or 10,000 (M=53, F=49) IU daily vitamin D3. They were then scanned on high‐resolution peripheral quantitative computed tomography (HR‐pQCT) for measuring total volumetric BMD (TtBMD) at baseline, 6, 12, 24 and 36 months.
Finite element analysis estimated bone strength. Balance, physical function, and clinical biochemistry parameters were also assessed.
Key findings of the study include:
- Baseline, three‐month, and three‐year levels of 25(OH)D were 76.3, 76.7, and 77.4 nmol/L (400); 81.3, 115.3, and 132.2 (4000); and 78.4, 188.0, and 144.4 (10,000).
- There were significant time‐by‐treatment group‐by‐sex interactions for TtBMD at the radius and tibia.
- Treatment with 4000 or 10,000 compared to 400 IU resulted in TtBMD losses in females, but this was not observed with males.
- After three years, females lost 1.8% (400), 3.8% (4000) and 5.5% (10,000), whereas males lost 0.9% (400), 1.3% (4000) and 1.9% (10,000) at the radius.
- At the tibia, losses in TtBMD were smaller, but followed a similar trend.
- There were no significant bone strength interactions.
"Our findings do not support a benefit of high‐dose vitamin D supplementation for bone health, and raise the possibility of harm for females," concluded the authors.
The study was presented at the virtual meeting of ASBMR 2020 and published in the Journal of Bone and Mineral Research.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd